Research & Development
RUO: Page 2
PacBio launches long-read and short-read sequencing platforms for research
PacBio said that it has launched two new genome sequencing systems set to be available in 2023: the Revio long-read sequencing system and the Onso short-read sequencing system.
October 26, 2022
nRichDX launches products for researchers developing liquid biopsy assays
Both products are used with nRichDX’s Revolution Sample Prep System. Researchers use the system for high-yield extraction of rare cfDNA from 1 mL to 20 mL of either plasma or urine samples.
October 24, 2022
PacBio, Twist Bioscience collaborate to launch long-read gene panels for research
One panel covers nearly 400 challenging genes associated with spinal muscular atrophy, Alzheimer’s, cardiovascular disease, and other diseases.
October 19, 2022
Harvard NGS technique sheds light on hard-to-isolate cells
The technique is comparable to single-cell sequencing methods while simultaneously broadening the depth and scope of investigations possible on a tissue sample.
October 11, 2022
Gestalt Diagnostics receives CE-IVD marks for cloud-based digital pathology components
The company announced that it has received European regulatory certification for two components that are part of its PathFlow digital pathology platform.
October 10, 2022
Duke University developing RNA-based probe for disease management
The researchers contend that this tool could become a key technique in the managing of disease by simply modifying cells and their functions. It would offer a disease management tool that currently does not exist.
October 7, 2022
Bio-Techne releases automated codetection assays for Roche platform
Developed in partnership with Roche, the new automated multiomic assays use Bio-Techne's patented RNAscope and BaseScope signal amplification and background suppression technologies.
October 6, 2022
Spear Bio launches COVID immune-response RUO assay
The firm said its NAB-Sure SARS-CoV-2 test kit uses RT-PCR to simplify testing for SARS-CoV-2 neutralizing antibodies (NAbs) and provides qualitative and quantitative NAb titer measurements.
August 21, 2022
Roche RUO test detects latest SARS-CoV-2 subvariant
The test specifically targets two of the known unique mutations in BA.2.75, which allows clear differentiation from other notable subvariants, Roche said.
August 21, 2022
Qiagen launches syndromic monkeypox test for research
QIAstat-Dx Viral Vesicular Panel RUO comes in cartridge form and runs on the company's QIAstat-Dx automated syndromic testing devices. The panel allows medical researchers to detect monkeypox in about one hour using PCR-testing technology.
August 15, 2022
Thermo Fisher releases RUO assay for HIV variants
Specifically, the assay analyses HIV RNA extracted from ethylenediaminetetraacetic acid (EDTA) plasma or dried blood spots to measure genomic mutations in the protease, reverse transcriptase, and integrase regions of the pol gene.
August 7, 2022
Bruker launches long-COVID assessment test
The test, PhenoRiskPacs RuO, uses a multiplexed combination of biomarkers discovered at the Australian National Phenome Center at Murdoch University.
July 7, 2022
Page 2 of 3